spacer
spacer

PDBsum entry 1v66

Go to PDB code: 
protein links
Ligase PDB id
1v66

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
65 a.a. *
* Residue conservation analysis
PDB id:
1v66
Name: Ligase
Title: Solution structure of human p53 binding domain of pias-1
Structure: Protein inhibitor of activated stat protein 1. Chain: a. Fragment: residues 1-65. Synonym: protein inhibitor of activated stat-1, pias-1, gu binding protein, gbp, RNA helicase ii binding protein, dead/h box-binding protein 1. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
NMR struc: 20 models
Authors: S.Okubo,F.Hara,Y.Tsuchida,S.Shimotakahara,S.Suzuki,H.Hatanaka, S.Yokoyama,H.Tanaka,H.Yasuda,H.Shindo,Riken Structural Genomics/proteomics Initiative (Rsgi)
Key ref:
S.Okubo et al. (2004). NMR structure of the N-terminal domain of SUMO ligase PIAS1 and its interaction with tumor suppressor p53 and A/T-rich DNA oligomers. J Biol Chem, 279, 31455-31461. PubMed id: 15133049 DOI: 10.1074/jbc.M403561200
Date:
27-Nov-03     Release date:   07-Dec-04    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
O75925  (PIAS1_HUMAN) -  E3 SUMO-protein ligase PIAS1 from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
651 a.a.
65 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.2.3.2.-  - ?????
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

 

 
DOI no: 10.1074/jbc.M403561200 J Biol Chem 279:31455-31461 (2004)
PubMed id: 15133049  
 
 
NMR structure of the N-terminal domain of SUMO ligase PIAS1 and its interaction with tumor suppressor p53 and A/T-rich DNA oligomers.
S.Okubo, F.Hara, Y.Tsuchida, S.Shimotakahara, S.Suzuki, H.Hatanaka, S.Yokoyama, H.Tanaka, H.Yasuda, H.Shindo.
 
  ABSTRACT  
 
A member of the PIAS (protein inhibitor of activated STAT) family of proteins, PIAS1, have been reported to serve as an E3-type SUMO ligase for tumor suppressor p53 and its own. It also was proposed that the N-terminal domain of PIAS1 interacts with DNA as well as p53. Extensive biochemical studies have been devoted recently to understand sumoylations and its biological implications, whereas the structural aspects of the PIAS family and the mechanism of its interactions with various factors are less well known to date. In this study, the three-dimensional structure of the N-terminal domain (residues 1-65) of SUMO ligase PIAS1 was determined by NMR spectroscopy. The structure revealed a unique four-helix bundle with a topology of an up-down-extended loop-down-up, a part of which the helix-extended loop-helix represented the SAP (SAF-A/B, Acinus, and PIAS) motif. Thus, this N-terminal domain may be referred to as a four-helix SAP domain. The glutathione S-transferase pull-down assay demonstrated that this domain possesses a binding ability to tumor suppressor p53, a target protein for sumoylation by PIAS1, whereas gel mobility assays showed that it has a strong affinity toward A/T-rich DNA. An NMR analysis of the four-helix SAP domain complexed with the 16-bp-long DNA demonstrated that one end of the four-helix bundle is the binding site and may fit into the minor groove of DNA. The three-dimensional structure and its binding duality are discussed in conjunction with the biological functions of PIAS1 as a SUMO ligase.
 
  Selected figure(s)  
 
Figure 6.
FIG. 6. The highly perturbed residues of PIA-(1-65) upon its binding to DNA16 are colored in red ( > 0.3 ppm) and pink (0.3 ppm > > 0.1 ppm) in the side view (a) and the top view (b). Side chains of basic residues also are depicted in the model. C, C terminus; N, N terminus.
Figure 7.
FIG. 7. Stereoviews of the superimposed ribbon diagrams for the four-helix SAP domain, PIA-(1-65), with protease inhibitor Iceberg (Protein Data Bank code 1DGN [PDB] ) (a), the C-terminal domain of bacteriophage T4 endonuclease VII (Protein Data Bank code 1EN7 [PDB] ) (b), and the C-terminal domain of Ku70 (Protein Data Bank code 1JJR [PDB] ) (c). The N-terminal domain of PIAS1 is in blue, and the other domains are in red.
 
  The above figures are reprinted by permission from the ASBMB: J Biol Chem (2004, 279, 31455-31461) copyright 2004.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20422039 C.Alfonso-Parra, and K.A.Maggert (2010).
Drosophila SAF-B links the nuclear matrix, chromosomes, and transcriptional activity.
  PLoS One, 5, e10248.  
20351170 J.A.Tan, J.Song, Y.Chen, and L.K.Durrin (2010).
Phosphorylation-dependent interaction of SATB1 and PIAS1 directs SUMO-regulated caspase cleavage of SATB1.
  Mol Cell Biol, 30, 2823-2836.  
20715991 K.Kim, S.Bae, J.Hong, J.Choi, S.Ryoo, H.Jhun, S.Lee, E.Her, K.Hong, and S.Kim (2010).
Generation of monoclonal antibodies against recombinant AtSIZ1.
  Hybridoma (Larchmt), 29, 333-340.  
19526197 M.M.Rytinki, S.Kaikkonen, P.Pehkonen, T.Jääskeläinen, and J.J.Palvimo (2009).
PIAS proteins: pleiotropic interactors associated with SUMO.
  Cell Mol Life Sci, 66, 3029-3041.  
18831036 R.Suzuki, H.Shindo, A.Tase, Y.Kikuchi, M.Shimizu, and T.Yamazaki (2009).
Solution structures and DNA binding properties of the N-terminal SAP domains of SUMO E3 ligases from Saccharomyces cerevisiae and Oryza sativa.
  Proteins, 75, 336-347.
PDB codes: 2rnn 2rno
19043449 A.Vazquez, E.E.Bond, A.J.Levine, and G.L.Bond (2008).
The genetics of the p53 pathway, apoptosis and cancer therapy.
  Nat Rev Drug Discov, 7, 979-987.  
18701921 J.L.Parker, A.Bucceri, A.A.Davies, K.Heidrich, H.Windecker, and H.D.Ulrich (2008).
SUMO modification of PCNA is controlled by DNA.
  EMBO J, 27, 2422-2431.  
19076347 L.O.Tykocinski, A.Sinemus, and B.Kyewski (2008).
The thymus medulla slowly yields its secrets.
  Ann N Y Acad Sci, 1143, 105-122.  
18227428 M.Devany, F.Kappes, K.M.Chen, D.M.Markovitz, and H.Matsuo (2008).
Solution NMR structure of the N-terminal domain of the human DEK protein.
  Protein Sci, 17, 205-215.
PDB code: 2jx3
19008896 P.Peterson, T.Org, and A.Rebane (2008).
Transcriptional regulation by AIRE: molecular mechanisms of central tolerance.
  Nat Rev Immunol, 8, 948-957.  
18815416 Y.J.Lin, T.Umehara, M.Inoue, K.Saito, T.Kigawa, M.K.Jang, K.Ozato, S.Yokoyama, B.Padmanabhan, and P.Güntert (2008).
Solution structure of the extraterminal domain of the bromodomain-containing protein BRD4.
  Protein Sci, 17, 2174-2179.  
18363965 Y.Tsuji, K.Watanabe, K.Araki, M.Shinohara, Y.Yamagata, T.Tsurimoto, F.Hanaoka, K.Yamamura, M.Yamaizumi, and S.Tateishi (2008).
Recognition of forked and single-stranded DNA structures by human RAD18 complexed with RAD6B protein triggers its recruitment to stalled replication forks.
  Genes Cells, 13, 343-354.  
18492068 Z.Tang, C.M.Hecker, A.Scheschonka, and H.Betz (2008).
Protein interactions in the sumoylation cascade: lessons from X-ray structures.
  FEBS J, 275, 3003-3015.  
17584785 J.Lee, J.Beliakoff, and Z.Sun (2007).
The novel PIAS-like protein hZimp10 is a transcriptional co-activator of the p53 tumor suppressor.
  Nucleic Acids Res, 35, 4523-4534.  
17178721 J.X.Du, C.C.Yun, A.Bialkowska, and V.W.Yang (2007).
Protein inhibitor of activated STAT1 interacts with and up-regulates activities of the pro-proliferative transcription factor Krüppel-like factor 5.
  J Biol Chem, 282, 4782-4793.  
17720710 V.Notenboom, R.G.Hibbert, S.E.van Rossum-Fikkert, J.V.Olsen, M.Mann, and T.K.Sixma (2007).
Functional characterization of Rad18 domains for Rad6, ubiquitin, DNA binding and PCNA modification.
  Nucleic Acids Res, 35, 5819-5830.  
17603101 X.L.Chen, H.R.Silver, L.Xiong, I.Belichenko, C.Adegite, and E.S.Johnson (2007).
Topoisomerase I-dependent viability loss in saccharomyces cerevisiae mutants defective in both SUMO conjugation and DNA repair.
  Genetics, 177, 17-30.  
16522640 J.R.Prigge, and E.E.Schmidt (2006).
Interaction of protein inhibitor of activated STAT (PIAS) proteins with the TATA-binding protein, TBP.
  J Biol Chem, 281, 12260-12269.  
16894028 T.M.Wise-Draper, H.V.Allen, E.E.Jones, K.B.Habash, H.Matsuo, and S.I.Wells (2006).
Apoptosis inhibition by the human DEK oncoprotein involves interference with p53 functions.
  Mol Cell Biol, 26, 7506-7519.  
15722484 F.Böhm, F.Kappes, I.Scholten, N.Richter, H.Matsuo, R.Knippers, and T.Waldmann (2005).
The SAF-box domain of chromatin protein DEK.
  Nucleic Acids Res, 33, 1101-1110.  
16056253 K.Shuai, and B.Liu (2005).
Regulation of gene-activation pathways by PIAS proteins in the immune system.
  Nat Rev Immunol, 5, 593-605.  
15933717 Y.Azuma, A.Arnaoutov, T.Anan, and M.Dasso (2005).
PIASy mediates SUMO-2 conjugation of Topoisomerase-II on mitotic chromosomes.
  EMBO J, 24, 2172-2182.  
15572666 E.Munarriz, D.Barcaroli, A.Stephanou, P.A.Townsend, C.Maisse, A.Terrinoni, M.H.Neale, S.J.Martin, D.S.Latchman, R.A.Knight, G.Melino, and V.De Laurenzi (2004).
PIAS-1 is a checkpoint regulator which affects exit from G1 and G2 by sumoylation of p73.
  Mol Cell Biol, 24, 10593-10610.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer